Events and Congresses

Bioxydyn at ISMRM, Honolulu

12 Apr 2017

Discover the latest advances in MRI biomarkers and their successful implementation for decision making in clinical trials. Learn how Bioxydyn can help you evaluate your drug pipeline and how Pulmolux can help quantitatively analyse your lung MR. Advances that will be presented by Bioxydyn and our collaborators at ISMRM include:

Dynamic contrast enhanced (DCE) MRI
Oxygen-enhanced (OE) MRI
Diffusion weighted imaging (DWI)

Applications of these technologies include:

Pulmonary disease — e.g. asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD), idiopathic fibrosis (IPF), pulmonary embolism (PE), and pulmonary hypertension
Oncology — e.g. tumor vasculature, metabolism and hypoxia
CNS — e.g. Alzheimer’s disease (AD), multiple sclerosis (MS), stroke, and developmental disorders
Inflammation – e.g. rheumatoid arthritis (RA), osteoarthritis (OA), psoriatic arthritis, Crohn’s disease
Hepatology — e.g. liver transporter function, perfusion, and tissue quality

Pick a time to chat at ISMRM with Geoff Parker, Bioxydyn CEO, or Jose Ulloa, Head of Imaging Physics at Bioxydyn.

« Back to Events